Myriad Genetics Stock Technical Analysis

MYGN Stock  USD 16.27  0.01  0.06%   
As of the 1st of December, Myriad Genetics secures the Risk Adjusted Performance of (0.16), standard deviation of 3.47, and Mean Deviation of 2.21. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Myriad Genetics, as well as the relationship between them.

Myriad Genetics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Myriad, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Myriad
  
Myriad Genetics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Myriad Genetics Analyst Consensus

Target PriceAdvice# of Analysts
20.72Buy14Odds
Myriad Genetics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Myriad analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Myriad stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Myriad Genetics, talking to its executives and customers, or listening to Myriad conference calls.
Myriad Analyst Advice Details
Myriad Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Myriad Genetics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Myriad Genetics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Myriad Genetics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Myriad Genetics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Myriad Genetics Trend Analysis

Use this graph to draw trend lines for Myriad Genetics. You can use it to identify possible trend reversals for Myriad Genetics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Myriad Genetics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Myriad Genetics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Myriad Genetics applied against its price change over selected period. The best fit line has a slop of   0.25  , which may suggest that Myriad Genetics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 2382.19, which is the sum of squared deviations for the predicted Myriad Genetics price change compared to its average price change.

About Myriad Genetics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Myriad Genetics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Myriad Genetics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Myriad Genetics price pattern first instead of the macroeconomic environment surrounding Myriad Genetics. By analyzing Myriad Genetics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Myriad Genetics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Myriad Genetics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Dividend Yield0.370.22
Price To Sales Ratio2.12.0

Myriad Genetics December 1, 2024 Technical Indicators

Most technical analysis of Myriad help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Myriad from various momentum indicators to cycle indicators. When you analyze Myriad charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Myriad Genetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myriad Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myriad Genetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myriad Genetics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.28)
Revenue Per Share
9.205
Quarterly Revenue Growth
0.112
Return On Assets
(0.05)
Return On Equity
(0.16)
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.